Rogerio C. Lilenbaum MD

Professor of Medicine (Medical Oncology); Chief Medical Officer of Smilow Cancer Hospital

Clinical Interests

lung cancer; lung cancer treatment in older patients


Board Certifications

1998
Hematology, Internal Medicine, Board Certified
1995
Internal Medicine, Board Certified
1997
Medical Oncology, Board Certified

Patient Care Locations

 
rogerio_lilenbaumfaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Lung A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects With Advanced Non-Small Cell Lung Cancer
Bladder, Breast - Female, Lung, Pancreas, and Stomach A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
Lung and Melanoma, skin A Phase 2 Study of MK-3475 in patients with metastatic melanoma and non-small cell lung cancer with untreated brain metastases
Lung A Phase 2b, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second- or Third-line Treatment of Subjects with Unresectable Pleural or Peritoneal Malignant Mesothelioma
Lung A Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)

More Clinical Trials...

Edit Profile